Galmed Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLMD and other ETFs, options, and stocks.About GLMD
Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus.
CEOAllen Baharaff
CEOAllen Baharaff
Employees8
Employees8
HeadquartersRamat Gan, Tel Aviv
HeadquartersRamat Gan, Tel Aviv
Founded2000
Founded2000
Employees8
Employees8
GLMD Key Statistics
Market cap2.37M
Market cap2.37M
Price-Earnings ratio-0.15
Price-Earnings ratio-0.15
Dividend yield—
Dividend yield—
Average volume66.18K
Average volume66.18K
High today$0.3949
High today$0.3949
Low today$0.373
Low today$0.373
Open price$0.3949
Open price$0.3949
Volume27.15K
Volume27.15K
52 Week high$7.80
52 Week high$7.80
52 Week low$0.26
52 Week low$0.26